The table below shows Krystal Biotech, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$80.38M
$30.97M
$15.89M
-$26.16M
-$15.49M
-$9.65M
Capital expenditure
$7.15M
$6.20M
$1.26M
$5.38M
$17.19M
$2.47M
Investing cash flow
-$63.58M
-$54.77M
-$25.98M
$3.56M
-$55.91M
-$747.00K
Dividends paid
-
-
-
-
KRYS operating cash flow (10-K history)
Krystal Biotech, Inc. reported operating cash flow of $200.87M for fiscal year 2025. That is up 62.7% from $123.42M in fiscal 2024. Over the 8 fiscal years shown, operating cash flow grew from -$9.45M (FY 2018) to $200.87M. Figures come from the company's audited annual reports as filed with the SEC.
